119
Views
10
CrossRef citations to date
0
Altmetric
Original Article: Clinical

VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly

, , , , , , , , , , & show all
Pages 2167-2171 | Received 27 Jun 2007, Accepted 20 Aug 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sara Beygi, Santhosh Sadashiv, James B Reilly, Cyrus Khan & John Lister. (2018) Frontline treatment of diffuse large B-cell lymphoma in elderly: a systematic review of clinical trials in post-rituximab era. Leukemia & Lymphoma 59:12, pages 2847-2861.
Read now
Emanuele Cencini, Alberto Fabbri, Luana Schiattone, Francesco Gentili, Maria Antonietta Mazzei & Monica Bocchia. (2018) Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma. Acta Clinica Belgica 73:6, pages 408-412.
Read now

Articles from other publishers (8)

Takahide Taniguchi, Shoko Nakayama, Hirokazu Tanaka, Shinya Rai, Chikara Hirase, Yasuyoshi Morita, Yoichi Tatsumi, Takashi Ashida, Mitsuhiro Matsuda, Shigeo Hashimoto & Itaru Matsumura. (2022) Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL ‐6 production in lymphoma cells . British Journal of Haematology 198:2, pages 360-372.
Crossref
Sanja Trajkova, Svetlana Krstevska-Balkanov, Gordana Petrusevska, Lidija Cevreska, Aleksandra Pivkova-Veljanovska, Marija Popova-Labacevska, Nevenka Ridova, Simona Stojanovska & Irina Panovska-Stavridis. (2021) Prognostic impact of immunophenotyping of diffuse large B-cell lymphoma - a single-centre experience. Macedonian Pharmaceutical Bulletin 67:1, pages 43-54.
Crossref
Alberto Fabbri, Emanuele Cencini & Monica Bocchia. (2015) Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma. Cancer 121:20, pages 3746-3747.
Crossref
Enrico Derenzini, Beatrice Casadei, Cinzia Pellegrini, Lisa Argnani, Stefano Pileri & Pier Luigi Zinzani. (2013) Non-Hodgkin Lymphomas Presenting as Soft Tissue Masses: A Single Center Experience and Meta-Analysis of the Published Series. Clinical Lymphoma Myeloma and Leukemia 13:3, pages 258-265.
Crossref
Alessandro Broccoli, Vittorio Stefoni, Luca Faccioli, Claudio Agostinelli, Luca Spinardi, Marco Pastore Trossello & Pier Luigi Zinzani. (2011) Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. Rheumatology International 32:7, pages 2209-2213.
Crossref
Pier Luigi Zinzani, Letizia Gandolfi, Alessandro Broccoli, Lisa Argnani, Stefano Fanti, Cinzia Pellegrini, Vittorio Stefoni, Enrico Derenzini, Federica Quirini & Michele Baccarani. (2010) Midtreatment 18 F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma . Cancer 117:5, pages 1010-1018.
Crossref
Kazuyoshi Ishii, Fumiaki Urase, Yasuaki Nagare, Hidetsugu Kimura, Masahiro Manabe, Toshiya Yagi, Hirofumi Teshima, Kunio Hayashi, Masaru Shibano, Machiko Tsukaguchi, Tatsuya Katsurada, Atsuko Mugitani, Hitoshi Kitayama & Shosaku Nomura. (2010) VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. Archives of Gerontology and Geriatrics 51:2, pages 209-215.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:2, pages 115-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.